Geovax Labs Stock Performance
| GOVXW Stock | USD 0.05 0.03 36.12% |
The company retains a Market Volatility (i.e., Beta) of 0.28, which attests to not very significant fluctuations relative to the market. As returns on the market increase, GeoVax Labs' returns are expected to increase less than the market. However, during the bear market, the loss of holding GeoVax Labs is expected to be smaller as well. At this point, GeoVax Labs has a negative expected return of -0.16%. Please make sure to check out GeoVax Labs' sortino ratio, semi variance, rate of daily change, as well as the relationship between the value at risk and kurtosis , to decide if GeoVax Labs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days GeoVax Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors. ...more
1 | GeoVax Q3 Loss Narrows to 5.8M as BARDA Contract Boosts Revenue to 2.8M GOVX Stock News - StockTitan | 11/12/2024 |
2 | Acquisition by Chase Randal D of 16613 shares of GeoVax Labs at 5.0 subject to Rule 16b-3 | 11/22/2024 |
3 | Acquisition by Reynolds Mark of 60184 shares of GeoVax Labs at 5.0 subject to Rule 16b-3 | 01/14/2025 |
4 | Acquisition by Chase Randal D of 26400 shares of GeoVax Labs at 0.15 subject to Rule 16b-3 | 01/29/2025 |
5 | Acquisition by Mcnally Robert T of 53925 shares of GeoVax Labs at 5.0 subject to Rule 16b-3 | 02/24/2025 |
| Begin Period Cash Flow | 27.6 M |
GeoVax |
GeoVax Labs Relative Risk vs. Return Landscape
If you would invest 11.00 in GeoVax Labs on November 29, 2024 and sell it today you would lose (5.89) from holding GeoVax Labs or give up 53.55% of portfolio value over 90 days. GeoVax Labs is currently producing negative expected returns and takes up 18.2443% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than GeoVax, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
GeoVax Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeoVax Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GeoVax Labs, and traders can use it to determine the average amount a GeoVax Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0089
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GOVXW |
Estimated Market Risk
| 18.24 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average GeoVax Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GeoVax Labs by adding GeoVax Labs to a well-diversified portfolio.
GeoVax Labs Fundamentals Growth
GeoVax Stock prices reflect investors' perceptions of the future prospects and financial health of GeoVax Labs, and GeoVax Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GeoVax Stock performance.
| Return On Equity | -2.76 | ||||
| Return On Asset | -1.12 | ||||
| Operating Margin | (2.10) % | ||||
| Gross Profit | (19.25 M) | ||||
| EBITDA | (26.67 M) | ||||
| Net Income | (25.97 M) | ||||
| Cash And Equivalents | 710.68 K | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 3.52 M | ||||
| Current Ratio | 0.34 X | ||||
| Book Value Per Share | 0.99 X | ||||
| Cash Flow From Operations | (25.17 M) | ||||
| Total Asset | 9.28 M | ||||
| Retained Earnings | (104.36 M) | ||||
| Working Capital | 4.37 M | ||||
About GeoVax Labs Performance
Evaluating GeoVax Labs' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if GeoVax Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GeoVax Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (1.32) | (1.26) | |
| Return On Tangible Assets | (2.52) | (2.64) | |
| Return On Capital Employed | (4.18) | (3.97) | |
| Return On Assets | (2.52) | (2.64) | |
| Return On Equity | (5.18) | (4.92) |
Things to note about GeoVax Labs performance evaluation
Checking the ongoing alerts about GeoVax Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GeoVax Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GeoVax Labs generated a negative expected return over the last 90 days | |
| GeoVax Labs has high historical volatility and very poor performance | |
| GeoVax Labs has some characteristics of a very speculative penny stock | |
| GeoVax Labs has a very high chance of going through financial distress in the upcoming years | |
| GeoVax Labs has accumulated 3.52 M in total debt. GeoVax Labs has a current ratio of 0.33, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about GeoVax Labs' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (25.97 M) with loss before overhead, payroll, taxes, and interest of (19.25 M). | |
| GeoVax Labs has accumulated about 710.68 K in cash with (25.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from MacroaxisInsider: Acquisition by Mcnally Robert T of 53925 shares of GeoVax Labs at 5.0 subject to Rule 16b-3 |
- Analyzing GeoVax Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GeoVax Labs' stock is overvalued or undervalued compared to its peers.
- Examining GeoVax Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GeoVax Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of GeoVax Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GeoVax Labs' stock. These opinions can provide insight into GeoVax Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.